Spirocyclic Iodonium Ylides for Fluorine‐18 Radiolabeling of Non‐Activated Arenes: From Concept to Clinical Research

Positron emission tomography (PET) is a powerful imaging tool for drug discovery, clinical diagnosis, and monitoring of disease progression. Fluorine-18 is the most common radionuclide used for PET, but advances in radiotracer development have been limited by the historical lack of methodologies and precursors amenable to radiolabeling with fluorine-18. Radiolabeling of electron-rich (hetero)aromatic rings remains a long-standing challenge in the production of PET radiopharmaceuticals. In this personal account, we discuss the history of spirocyclic iodonium ylide precursors, from inception to applications in clinical research, for the incorporation of fluorine-18 into complex non-activated (hetero)aromatic rings.

[1]  I. Pronin,et al.  Radiochemical Synthesis of 4-[18F]FluorobenzylAzide and Its Conjugation with EGFR-Specific Aptamers , 2022, Molecules.

[2]  C. Elmore,et al.  Isotopic Radiolabeling of Crizotinib with Fluorine-18 for In Vivo Pet Imaging , 2022, Pharmaceuticals.

[3]  Qinggang He,et al.  Highly Efficient Radiosynthesis and Biological Evaluation of [18F]Safinamide, a Radiolabelled Anti‐Parkinsonian Drug for Positron Emission Tomography Imaging , 2022, ChemMedChem.

[4]  Hao Xu,et al.  Easily automated radiosynthesis of [18F]P10A-1910 and its clinical translation to quantify phosphodiesterase 10A in human brain , 2022, Frontiers in Bioengineering and Biotechnology.

[5]  Alexander M. Spokoyny,et al.  An Organometallic Gold(III) Reagent for 18F Labeling of Unprotected Peptides and Sugars in Aqueous Media. , 2022, Organic letters.

[6]  D. Cheng,et al.  Fluorine-18: Radiochemistry and Target-Specific PET Molecular Probes Design , 2022, Frontiers in Chemistry.

[7]  M. Berk,et al.  Effect of Glucocorticoid and 11β-Hydroxysteroid-Dehydrogenase Type 1 (11β-HSD1) in Neurological and Psychiatric Disorders , 2022, The international journal of neuropsychopharmacology.

[8]  Steven H. Liang,et al.  Discovery of a highly specific 18F-labeled PET ligand for phosphodiesterase 10A enabled by novel spirocyclic iodonium ylide radiofluorination , 2021, Acta pharmaceutica Sinica. B.

[9]  E. Suuronen,et al.  Cardiac Sympathetic Positron Emission Tomography Imaging with Meta-[18F]Fluorobenzylguanidine is Sensitive to Uptake-1 in Rats. , 2021, ACS chemical neuroscience.

[10]  B. Cornelissen,et al.  Closing the gap between 19F and 18F chemistry , 2021, EJNMMI Radiopharmacy and Chemistry.

[11]  B. Gulyás,et al.  Positron emission tomographic imaging in drug discovery. , 2021, Drug discovery today.

[12]  H. Gali.  Development of radiopharmaceuticals for PET renography , 2021, Journal of Chemical Sciences.

[13]  V. Shalgunov,et al.  Aliphatic 18F‐Radiofluorination: Recent Advances in the Labeling of Base‐Sensitive Substrates ** , 2021, ChemMedChem.

[14]  G. V. van Dongen,et al.  State of the Art in Radiolabeling of Antibodies with Common and Uncommon Radiometals for Preclinical and Clinical Immuno-PET , 2021, Bioconjugate chemistry.

[15]  Florent L Besson,et al.  PET Molecular Imaging: A Holistic Review of Current Practice and Emerging Perspectives for Diagnosis, Therapeutic Evaluation and Prognosis in Clinical Oncology , 2021, International journal of molecular sciences.

[16]  N. Tolboom,et al.  Nuclear Medicine Imaging in Neuroblastoma: Current Status and New Developments , 2021, Journal of personalized medicine.

[17]  A. van Waarde,et al.  PET Agents in Dementia: An Overview. , 2021, Seminars in nuclear medicine.

[18]  S. Underwood,et al.  Nuclear cardiology: state of the art , 2021, Heart.

[19]  Yiyun Huang,et al.  First-in-Human Evaluation of 18F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A , 2020, The Journal of Nuclear Medicine.

[20]  Steven H. Liang,et al.  Recent developments on PET radiotracers for TSPO and their applications in neuroimaging , 2020, Acta pharmaceutica Sinica. B.

[21]  C. Behrens,et al.  Fluorine-18 labelled aldehydes as prosthetic groups for oxime coupling with a FVIIa protein. , 2020, Journal of labelled compounds & radiopharmaceuticals.

[22]  D. Turton,et al.  18F-meta-fluorobenzylguanidine (18F-mFBG) to monitor changes in norepinephrine transporter expression in response to therapeutic intervention in neuroblastoma models , 2020, Scientific Reports.

[23]  A. Poot,et al.  The Current Status and Future Potential of Theranostics to Diagnose and Treat Childhood Cancer , 2020, Frontiers in Oncology.

[24]  Allen F. Brooks,et al.  On the consensus nomenclature rules for radiopharmaceutical chemistry - Reconsideration of radiochemical conversion. , 2020, Nuclear medicine and biology.

[25]  Allen F. Brooks,et al.  Copper-mediated late-stage radiofluorination: five years of impact on preclinical and clinical PET imaging , 2020, Clinical and Translational Imaging.

[26]  Yiyun Huang,et al.  Positron Emission Tomography Imaging Evaluation of a Novel 18F-Labeled Sigma-1 Receptor Radioligand in Cynomolgus Monkeys. , 2020, ACS chemical neuroscience.

[27]  R. Jeraj,et al.  Recent advances of PET imaging in clinical radiation oncology , 2020, Radiation oncology.

[28]  Yiyun Huang,et al.  Body Mass Index and Age Effects on Brain 11β-Hydroxysteroid Dehydrogenase Type 1: a Positron Emission Tomography Study , 2020, Molecular Imaging and Biology.

[29]  S. Baez,et al.  Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders. , 2020, Brain : a journal of neurology.

[30]  Steven H. Liang,et al.  Revisiting the Radiosynthesis of [18F]FPEB and Preliminary PET Imaging in a Mouse Model of Alzheimer’s Disease , 2020, Molecules.

[31]  Yiyun Huang,et al.  Synthesis and Preclinical Evaluation of an 18F-Labeled Synaptic Vesicle Glycoprotein 2A PET Imaging Probe: [18F]SynVesT-2. , 2020, ACS chemical neuroscience.

[32]  Steven H. Liang,et al.  A concisely automated synthesis of TSPO radiotracer [18 F]FDPA based on spirocyclic iodonium ylide (SCIDY) method and validation for human use. , 2020, Journal of labelled compounds & radiopharmaceuticals.

[33]  Joanne Wang,et al.  Targeting uptake transporters for cancer imaging and treatment , 2019, Acta pharmaceutica Sinica. B.

[34]  J. Narula,et al.  Nuclear Imaging of the Cardiac Sympathetic Nervous System: A Disease-Specific Interpretation in Heart Failure. , 2020, JACC. Cardiovascular imaging.

[35]  R. Bharath,et al.  Fluorine-18: A radionuclide with diverse range of radiochemistry and synthesis strategies for target based PET diagnosis. , 2019, European journal of medicinal chemistry.

[36]  D. Raffel,et al.  Improved synthesis of 4-[18 F]fluoro-m-hydroxyphenethylguanidine using an iodonium ylide precursor. , 2019, Journal of labelled compounds & radiopharmaceuticals.

[37]  A. Kjær,et al.  One-Step Synthesis of N-Succinimidyl-4-[18F]Fluorobenzoate ([18F]SFB) , 2019, Molecules.

[38]  A. Dunn,et al.  The synaptic vesicle glycoprotein 2: structure, function, and disease relevance. , 2019, ACS chemical neuroscience.

[39]  Steven H. Liang,et al.  Design, Synthesis and Evaluation of 18F-labeled Monoacylglycerol Lipase Inhibitors as Novel Positron Emission Tomography Probes. , 2019, Journal of medicinal chemistry.

[40]  J. Hodges,et al.  Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders , 2019, International journal of molecular sciences.

[41]  T. Beck,et al.  Therapeutic Potential of Kappa Opioid Agonists , 2019, Pharmaceuticals.

[42]  K. Blennow,et al.  Synaptic vesicle protein 2A as a potential biomarker in synaptopathies , 2019, Molecular and Cellular Neuroscience.

[43]  Steven H. Liang,et al.  Facile 18F labeling of non-activated arenes via a spirocyclic iodonium(III) ylide method and its application in the synthesis of the mGluR5 PET radiopharmaceutical [18F]FPEB , 2019, Nature Protocols.

[44]  Yiyun Huang,et al.  Imaging the Enzyme 11β-Hydroxysteroid Dehydrogenase Type 1 with PET: Evaluation of the Novel Radiotracer 11C-AS2471907 in Human Brain , 2019, The Journal of Nuclear Medicine.

[45]  Steven H. Liang,et al.  Chemie der Positronenemissionstomographie: Aktuelle Fortschritte bei 11 C‐, 18 F‐, 13 N‐ und 15 O‐Markierungsreaktionen , 2019, Angewandte Chemie.

[46]  Steven P Rowe,et al.  Novel Structured Reporting Systems for Theranostic Radiotracers , 2019, The Journal of Nuclear Medicine.

[47]  Steven H. Liang,et al.  Synthesis and Preliminary Evaluations of a Triazole-Cored Antagonist as a PET Imaging Probe ([18F]N2B-0518) for GluN2B Subunit in the Brain. , 2019, ACS chemical neuroscience.

[48]  Yiyun Huang,et al.  A Novel 18F-Labeled Radioligand for Positron Emission Tomography Imaging of 11β-Hydroxysteroid Dehydrogenase (11β-HSD1): Synthesis and Preliminary Evaluation in Nonhuman Primates. , 2019, ACS chemical neuroscience.

[49]  Cheng-Ta Li,et al.  Glutamatergic Dysfunction and Glutamatergic Compounds for Major Psychiatric Disorders: Evidence From Clinical Neuroimaging Studies , 2019, Front. Psychiatry.

[50]  Nabeel Nabulsi,et al.  PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases , 2019, Neuroscience Letters.

[51]  Yiyun Huang,et al.  Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman Primates. , 2018, ACS chemical neuroscience.

[52]  Yahiya Y. Syed.  Lorlatinib: First Global Approval , 2019, Drugs.

[53]  L. Josephson,et al.  Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO , 2018, Molecular imaging.

[54]  M. Sloan,et al.  Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies , 2018, Acta Pharmacologica Sinica.

[55]  K. Sander,et al.  Ring-Closing Synthesis of Dibenzothiophene Sulfonium Salts and Their Use as Leaving Groups for Aromatic 18F-Fluorination , 2018, Journal of the American Chemical Society.

[56]  Ming-Rong Zhang,et al.  [18F]DAA1106: Automated radiosynthesis using spirocyclic iodonium ylide and preclinical evaluation for positron emission tomography imaging of translocator protein (18 kDa). , 2018, Bioorganic & medicinal chemistry.

[57]  Eugene E. Kwan,et al.  Concerted Nucleophilic Aromatic Substitutions , 2018, Nature Chemistry.

[58]  Yiyun Huang,et al.  Novel 18F-Labeled κ-Opioid Receptor Antagonist as PET Radiotracer: Synthesis and In Vivo Evaluation of 18F-LY2459989 in Nonhuman Primates , 2018, The Journal of Nuclear Medicine.

[59]  R. Mach,et al.  Consensus nomenclature rules for radiopharmaceutical chemistry - Setting the record straight. , 2017, Nuclear medicine and biology.

[60]  Steven H. Liang,et al.  Brain Penetration of the ROS1/ALK Inhibitor Lorlatinib Confirmed by PET , 2017, Molecular imaging.

[61]  Steven H. Liang,et al.  Synthesis and preliminary PET imaging of 11C and 18F isotopologues of the ROS1/ALK inhibitor lorlatinib , 2017, Nature Communications.

[62]  Steven H. Liang,et al.  A Facile Radiolabeling of [18F]FDPA via Spirocyclic Iodonium Ylides: Preliminary PET Imaging Studies in Preclinical Models of Neuroinflammation. , 2017, Journal of medicinal chemistry.

[63]  B. Neumaier,et al.  Alcohol-Enhanced Cu-Mediated Radiofluorination. , 2017, Chemistry.

[64]  Yiyun Huang,et al.  PET Imaging Evaluation of Four σ1 Radiotracers in Nonhuman Primates , 2017, The Journal of Nuclear Medicine.

[65]  Xiaoyuan Chen,et al.  Combinatorial Screening of DNA Aptamers for Molecular Imaging of HER2 in Cancer. , 2017, Bioconjugate chemistry.

[66]  Sohita Dhillon,et al.  Safinamide: A Review in Parkinson’s Disease , 2017, CNS Drugs.

[67]  M. Herth,et al.  Nucleophilic 18F‐Labeling of Spirocyclic Iodonium Ylide or Boronic Pinacol Ester Precursors: Advantages and Disadvantages , 2017 .

[68]  Yiyun Huang,et al.  Fluorine-18-Labeled Antagonist for PET Imaging of Kappa Opioid Receptors. , 2017, ACS chemical neuroscience.

[69]  J. Rinne,et al.  Radiosynthesis and Preclinical Evaluation of [18F]F-DPA, A Novel Pyrazolo[1,5a]pyrimidine Acetamide TSPO Radioligand, in Healthy Sprague Dawley Rats , 2017, Molecular Imaging and Biology.

[70]  Allen F. Brooks,et al.  Copper-Mediated Radiofluorination of Arylstannanes with [18F]KF , 2016, Organic letters.

[71]  B. Neumaier,et al.  Automated synthesis of 4-[(18)F]fluoroanisole, [(18)F]DAA1106 and 4-[(18)F]FPhe using Cu-mediated radiofluorination under "minimalist" conditions. , 2016, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[72]  H. Coenen,et al.  Synthesis of a Potent Aminopyridine-Based nNOS-Inhibitor by Two Recent No-Carrier-Added 18F-Labelling Methods , 2016, Molecules.

[73]  S. Aznar,et al.  The 5-HT2A serotonin receptor in executive function: Implications for neuropsychiatric and neurodegenerative diseases , 2016, Neuroscience & Biobehavioral Reviews.

[74]  J. Hooker,et al.  Concerted nucleophilic aromatic substitution with 19F− and 18F− , 2016, Nature.

[75]  A. Hedrick,et al.  Facile synthesis of para-[(18)F]fluorohippurate via iodonium ylide-mediated radiofluorination for PET renography. , 2016, Bioorganic & medicinal chemistry letters.

[76]  Allen F. Brooks,et al.  Synthesis of [18F]Arenes via the Copper-Mediated [18F]Fluorination of Boronic Acids , 2015, Organic letters.

[77]  Steven H. Liang,et al.  18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression , 2015, The Journal of Nuclear Medicine.

[78]  Steven H. Liang,et al.  Ortho-Stabilized (18) F-Azido Click Agents and their Application in PET Imaging with Single-Stranded DNA Aptamers. , 2015, Angewandte Chemie.

[79]  Steven H. Liang,et al.  Synthesis of 18F-Arenes from Spirocyclic Iodonium(III) Ylides via Continuous-Flow Microfluidics. , 2015, Journal of fluorine chemistry.

[80]  B. Shulkin,et al.  A practical, automated synthesis of meta-[(18)F]fluorobenzylguanidine for clinical use. , 2015, ACS chemical neuroscience.

[81]  J. Holland,et al.  Computational studies on hypervalent iodonium(III) compounds as activated precursors for 18F radiofluorination of electron-rich arenes , 2015 .

[82]  Xiaoyuan Chen,et al.  PET Imaging of Tenascin-C with a Radiolabeled Single-Stranded DNA Aptamer , 2015, The Journal of Nuclear Medicine.

[83]  Steven H. Liang,et al.  Iodonium Ylide–Mediated Radiofluorination of 18F-FPEB and Validation for Human Use , 2015, The Journal of Nuclear Medicine.

[84]  F. Dollé,et al.  Efficient tritiation of the translocator protein (18 kDa) selective ligand DPA-714. , 2015, Journal of labelled compounds & radiopharmaceuticals.

[85]  H. Coenen,et al.  4-[18F]Fluorophenylpiperazines by Improved Hartwig-Buchwald N-Arylation of 4-[18F]fluoroiodobenzene, Formed via Hypervalent λ3-Iodane Precursors: Application to Build-Up of the Dopamine D4 Ligand [18F]FAUC 316 , 2014, Molecules.

[86]  J. Passchier,et al.  A general copper-mediated nucleophilic 18F fluorination of arenes. , 2014, Angewandte Chemie.

[87]  Steven H. Liang,et al.  Spirocyclic hypervalent iodine(III)-mediated radiofluorination of non-activated and hindered aromatics , 2014, Nature Communications.

[88]  Steven H. Liang,et al.  Alternative approaches for PET radiotracer development in Alzheimer's disease: imaging beyond plaque. , 2014, Journal of labelled compounds & radiopharmaceuticals.

[89]  Hong Liu,et al.  Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001-2011). , 2014, Chemical reviews.

[90]  J. Frampton.  Crizotinib: A Review of Its Use in the Treatment of Anaplastic Lymphoma Kinase-Positive, Advanced Non-Small Cell Lung Cancer , 2013, Drugs.

[91]  Qiang Zhou,et al.  NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease , 2013, Nature Reviews Neuroscience.

[92]  J. Ermert,et al.  Simplified synthesis of aryliodonium ylides by a one-pot procedure , 2013 .

[93]  S. Kourrich,et al.  The sigma-1 receptor: roles in neuronal plasticity and disease , 2012, Trends in Neurosciences.

[94]  A. Luxen,et al.  Fast and reliable method for the preparation of ortho- and para-[18F]fluorobenzyl halide derivatives: Key intermediates for the preparation of no-carrier-added PET aromatic radiopharmaceuticals , 2012 .

[95]  J. Mann,et al.  PET tracers for the peripheral benzodiazepine receptor and uses thereof. , 2010, Drug discovery today.

[96]  Alan A. Wilson,et al.  Radiolabeled Small Molecule Protein Kinase Inhibitors for Imaging with PET or SPECT , 2010, Molecules.

[97]  Jean-Claude Liehn,et al.  Positron Emission Tomography in oncology: present and future of PET and PET/CT. , 2009, Critical reviews in oncology/hematology.

[98]  A. Luxen,et al.  New strategy for the preparation of clickable peptides and labeling with 1-(azidomethyl)-4-[(18)F]-fluorobenzene for PET. , 2009, Bioconjugate chemistry.

[99]  Nicholas J Long,et al.  Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography. , 2008, Angewandte Chemie.

[100]  Kazutoshi Suzuki,et al.  A practical route for synthesizing a PET ligand containing [18F]fluorobenzene using reaction of diphenyliodonium salt with [18F]F− , 2007 .

[101]  H. Robertson,et al.  Role of phosphodiesterases in neurological and psychiatric disease. , 2007, Current opinion in pharmacology.

[102]  Yuji Nagai,et al.  Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: An imaging tool for glial cells in the brain , 2004, Synapse.